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Abstract
Background and aims Consensus is lacking on whether light to moderate consumption of alcohol compared to abstinence is 
neuroprotective. In this study, we investigated the relationship between self-reported alcohol use and brain volume change 
over 2 years in middle-aged subjects.
Methods A sample of 162 subjects (aged 40–59 at baseline) from the PREVENT-Dementia programme underwent MRI 
scans on two separate occasions (mean interval 734 days; SD 42 days). We measured longitudinal rates of brain atrophy 
using the FSL Siena toolbox, and change in hippocampal volume from segmentation in SPM.
Results Controlling for age and sex, there were no significant associations of either total brain, ventricular, or hippocampal 
volume change with alcohol consumption. Adjusting for lifestyle, demographic and vascular risk factors did not alter this.
Conclusions We did not find any evidence of influence of alcohol consumption on changes in brain volume over a 2-year 
period in 40–60-year-olds.
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Introduction
High consumption of alcohol has consistently been linked 
with dementia and brain degeneration; however, several, but 
not all, studies have suggested that moderate consumption 
vs. abstinence is a protective factor against dementia [1, 2]. 
Some studies of the association of alcohol consumption 
with brain volume have similarly found protective effects 
of light to moderate drinking [3], whilst others have found 
that brain volume tends to linearly decrease with increased 
alcohol intake [4]. Topiwala et al. [5] found higher alcohol 
consumption associated with smaller hippocampi, as con-
trasted with Downer et al. [6] who found larger hippocampi 
for those with moderate consumption. A systematic review 
concluded that hippocampal volume was reduced in those 
with problematic alcohol use [7]. All these studies used 
cross-sectional imaging data, and are thus not sensitive to 
any ongoing neurodegeneration.
The aim of this study was to investigate alcohol consump-
tion and longitudinal changes in brain volume in middle-
aged adults. We investigated whole brain and ventricular 
volume as well as hippocampal volume, due to its asso-
ciation with both alcohol dependence and dementia. We 
hypothesised that increased alcohol consumption would be 
associated with brain atrophy.
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Materials and methods
Subjects
The protocol has been described in detail elsewhere [8]. 
A total of 193 participants aged 40–59, of whom 168 had 
repeat MRI were recruited through multiple sources. Ini-
tially they were identified from the dementia register data-
base held at a London National Health Service (NHS) Trust, 
part of the UK National Health Service. Other participants 
were recruited via the Join Dementia Research website (https 
://www.joind ement iares earch .nihr.ac.uk/), through informa-
tion about the study on the Internet and public presentations. 
The study aimed to recruit approximately half of the subjects 
with a parental family history of dementia and half with-
out. All MRI scans obtained on participants were formally 
reported by an experienced consultant neuroradiologist. Any 
subject with significant incidental findings (e.g., tumour, 
stroke) was excluded. Approval for the study was given by 
the NHS Research Ethics Committee London Camberwell 
St-Giles (REC reference: 12/LO/1023). All participants pro-
vided informed written consent.
Imaging
Participants underwent multimodal 3 T structural mag-
netic resonance imaging on a single scanner (Siemens 
Verio) including volumetric T1-weighted scans (176 
slices, 1.0 × 1.0 mm, 1.0 mm slice thickness, repetition 
time = 2300 ms, echo time = 2.98 ms, flip angle 9°). Scans 
were repeated after approximately 2 years on the same scan-
ner using the same protocol. Imaging findings from these 
participants have been previously reported [9–11].
Percentage brain and ventricular volume change 
between the two scans were determined using the FSL 
SIENA program (https ://fsl.fmrib .ox.ac.uk/fsl/fslwi ki). 
Values were then divided by the time between scans to 
give rates per year. SPM12 (https ://www.fil.ion.ucl.ac.uk/
spm) was used to segment the brain into grey matter, white 
matter and CSF, and spatially normalise the images to 
standard space. To determine hippocampal volume, the 
hippocampal region of interest (ROI) from the AAL tem-
plate [12] was used to determine the mean of the normal-
ised grey matter segmentation image. Left and right were 
averaged, and the longitudinal change was determined by 
subtracting the baseline measurement from repeat. Total 
intracranial volume (ICV) was calculated from the sum 
of grey matter, white matter and CSF segmentation at 
baseline. All output was manually checked to ensure cor-
rect brain segmentation, and alignment of baseline/repeat 
scans.
Lifestyle variables
Demographic data and information on drinking and smok-
ing status were collected from case report forms which 
hold participants’ data collected at interview. We also 
included data from the participants’ medical history, which 
included history of alcoholism and diabetes. Participants 
were classified as current smokers or non-smokers (never 
and former).
We used the Lifetime of Experiences Questionnaire 
(LEQ) [13] to extract data about physical, social and cul-
tural activity (art, music, hobbies) from the age of 30 years 
to present. The three physical questions used from the 
LEQ asked participants how often they engaged in activi-
ties that were (1) mildly energetic (such as walking), (2) 
moderately energetic and (3) vigorous (such as running). 
For each activity, participants were asked to indicate their 
response on the six-point Likert scale from Never to Daily. 
We dichotomised the scores as to whether people did the 
activities more vs. less frequently than once a month.
Alcohol consumption in units per week was determined 
using the Scottish Collaborative Group Food Frequency 
Questionnaire version 7.1 (https ://www.foodf reque ncy.
org) completed by the participant at baseline and repeat 
visit. The questionnaire asks for the typical amount and 
frequency of consumption of 175 food and drink items 
over the last 2–3 months. We took the average of base-
line and repeat alcohol consumption, except for eight par-
ticipants for whom repeat values were missing, in which 
case we used the baseline value. Following previous 
research [5] and the UK guidelines of 14 units per week 
as a safe limit (https ://www.drink aware .co.uk/alcoh ol-
facts /alcoh olic-drink s-units /lates t-uk-alcoh ol-unit-guida 
nce/), alcohol usage was divided into abstaining (< 1 unit/
week), light (> = 1 and < 7 units/week), moderate (> = 7 
and < 14 units/week), high (> = 14 and < 21 units/week) 
and very high (> = 21 units per week). No distinction was 
applied between men and women in this classification. 
For a subgroup analysis on male and female separately, 
we divided alcohol use into three groups: (0–5), (> 5–15), 
(> 15) units per week to avoid having too few male sub-
jects in each group.
The Framingham risk score was used to calculate 10-year 
cardiovascular risk from current smoking status, systolic 
BP, BP medication status, sex, age at baseline, total and 
HDL cholesterol and diagnosis of diabetes. Social class was 
determined using the UK National Statistics Socio-economic 
classification (NS-SEC).
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Statistical analysis
Brain volume data and clinical variables were analysed with 
R version 3.5.2. Independent t tests were used to compare 
groups for continuous variables. Linear regression was used 
to investigate association of alcohol with brain atrophy rates. 
Total brain and ventricular volume change were expressed 
as percentage of baseline volume (as calculated by SIENA). 
For hippocampal analysis, we included ICV as a covariate 
to adjust for head size. Residuals were checked by eye to 
verify normality, heteroscedasticity and absence of nonlinear 
associations.
Results
Of the 193 participants with T1 MR scans at baseline, 168 
had a repeat scan. One participant was excluded as an outlier 
(ventricular change was negative, 3SD below mean). We 
excluded one subject due to missing alcohol consumption 
data, and four with a history of alcohol dependence, leaving 
162 in the main analysis.
Mean age at baseline was 52 year (SD 5.4), and mean 
interval between scans 734 (SD 42) days. There were 24 
alcohol abstainers, 42 light, 44 moderate, 20 high and 32 
very high consumers of alcohol. The highest intake group 
included six persons (four male) drinking > 50 units/week. 
There were 112 female and 50 male participants, with men 
having higher alcohol consumption than women 19.7 (SD 
21.3) vs. 10.9 (SD 12.1) units/week t63.5 = 2.74, p = 0.008, 
Welch two-sample t test.
Mean Framingham risk score was 6.6% (SD 5.5%, 
min = 0.9%, max = 47%). There were 25/162 participants 
who engaged in artistic, musical activities or hobbies at 
least once a fortnight; 149/161 who met family or friends; 
151/162 engaged in mild, 128/162 moderate, and 76/162 
vigorous activities. 85 participants had one or both parents 
with dementia, and there were six current smokers. Mean 
years of education was 16.1 (SD 3.4). There were 36 peo-
ple in social class one, 56 in class two, 22 in class three, 
10 in class four, 7 in classes five–seven and 26 in class 
eight, with 5 people not classified. 35 people had a medical 
history of depression, two of whom had a recurrence dur-
ing the study, and a further two had incident depression. 
Supplementary Tables 1 and 2 present these data split by 
alcohol consumption. The moderate consumption group 
had the lowest Framingham score, which was significantly 
lower than the abstainer group (p = 0.02, Tukey HSD post 
hoc). The abstainer group had significantly fewer years of 
education than the moderate (p = 0.007 Tukey HSD post 
hoc) and the very high group (p = 0.03 Tukey HSD post 
hoc).
In linear models including alcohol consumption, age, 
sex (and intracranial volume for hippocampus), there was 
no significant effect of alcohol on brain change (Table 1), 
although there was a trend (p = 0.09) of association 
between drinking 14–21 units of alcohol and preserved 
total brain volume (Table 1, Fig. 1). Addition of other 
factors (education, midlife activities, social class, vascu-
lar risk factors, family history of dementia) did not alter 
this lack of significant association between alcohol and 
longitudinal brain change [supplementary Tables 3, 4]. 
The addition of the four subjects with a history of alco-
hol dependence did not qualitatively alter the results. As 
sex was a strong predictor of atrophy, we also repeated 
the linear model analysis in male and female participants 
separately. In this, we split alcohol usage into three groups 
due to relatively low numbers of male participants. The 
demographics and results of the linear model are in Sup-
plementary Tables 5–7. There were no significant associa-
tions of brain volume change with alcohol in this analysis.
Table 1  Linear model predictors of annual percentage ventricle change, total brain volume change and hippocampal volume change
Alcohol values are referenced to the abstainer group (< 1 unit alcohol per week)
**p < 0.001
Percent ventricle change per year 
 F6,155 = 6.4; p < 0.001
Percent brain volume change per year 
 F6,155 = 2.98; p < 0.009
Hippocampal volume change per year 
 F7,154 = 3.58; p = 0.001
Beta (SE) Beta (SE) Beta (SE)
Age 0.16 (0.04) t = 4.59; p =  < 0.001** − 0.017 (0.005) t = − 3.68; 
p =  < 0.001**
− 0.11 (0.60) t = − 0.19; p = 0.848
Male sex 1.60 (0.43) t = 3.75; p =  < 0.001** 0.042 (0.056) t = 0.75; p = 0.452 0.70 (9.77) t = 0.07; p = 0.943
1–7 units/week 0.51 (0.62) t = 0.82; p = 0.414 0.073 (0.081) t = 0.90; p = 0.368 10.68 (10.33) t = 1.03; p = 0.303
7–14 units/week 0.72 (0.62) t = 1.16; p = 0.247 0.055 (0.081) t = 0.69; p = 0.493 0.09 (10.48) t = 0.01; p = 0.993
14–21 units/week -0.49 (0.73) t = − 0.67; p = 0.502 0.162 (0.095) t = 1.70; p = 0.091 2.73 (12.37) t = 0.22; p = 0.826
> 21 units/week 0.10 (0.66) t = 0.15; p = 0.883 0.061 (0.085) t = 0.71; p = 0.478 9.52 (10.96) t = 0.87; p = 0.386
Intracranial volume − 118.5 (35.0) t = − 3.39; p =  < 0.001**
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Discussion
Contrary to our hypothesis, we did not observe any signifi-
cant association between alcohol consumption and longitudi-
nal brain volume changes. Rather, we saw a non-significant 
trend of 14–21 units of alcohol (vs. abstinence) associated 
with preserved total brain volume.
Studies of alcohol on cognition or brain structure have 
confounds due to social and demographic factors, with age, 
years of education, and social class all being linked to both 
alcohol consumption and brain volume. Our study, look-
ing at brain volume change over 2 years within individuals 
overcomes to some extent these confounds, and including 
the lifestyle, demographic and vascular health factors in our 
analysis did not change our findings.
Combined with the previous conflicting reports on the 
benefit or otherwise of mild to moderate alcohol consump-
tion, our data suggest at least that consumption of 7–21 units 
per week is not associated with marked brain atrophy over a 
2-year period in midlife.
Limitations of the study include that alcohol consumption 
was estimated from subject report, and the relatively short 
follow-up of 2 years. The participants were mostly female, 
limiting the extrapolation to the general population.
In summary, we did not find any evidence of influence 
of alcohol consumption on changes in brain volume over a 
2-year period in 40–60-year-olds.
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